Refreshing results…
Phase I/II trial of a peptide-based COVID-19 T-cell activator in patients with B-cell deficiency
Download from doi.orgPreexisting and Post–COVID-19 Immune Responses to SARS-CoV-2 in Patients with Cancer
UploadMissing publications? Search for publications with a matching author name.